ONC Sales

How is Libtayo going?

 

Fantastic- docs excited about the drug and anxious to use it in other cancers.

 

congrats on a great Q4 and launch - $15m in sales

$120m in ‘19 is a layup.

 

what a dog! 15m, that blows

 

$50m max in 2019. Can’t feed a sales and marketing team on that level for long. Keep those resumes up to date.

 

Son of ZalCRAP.

 

Truth

 

Remember that’s the combined effort of Regeneron and Sanofi Genzyme sales forces.

What is that like 70 or 75 field-based salespeople and managers?

Revenue negative at this point.

 

it’s like 271

 

This drug is on fire.

 

On fire? We don’t even sell enough to cover our costs and the leadership is very disappointed you aren’t selling more. A tip, spend more time selling and less time posting. Again we’re very disappointed

 

Indeed- it’s a dumpster fire

 

it’s George’s other illegitimate bastard son. ZalCRAP and LibMAYO. Genius, sheer genius.

 

Not seeing it so far.

 

as someone else already said, it’s a dumpster fire.

 

Looks like GSK has a winner, not an also ran like metoovamab

 

Sucks

 

last day of Q2, looking forward to the next earnings call. Anxious to see Libtayo’s growth trajectory.

 

Earnings and Libmayo in the same sentence, now that’s funny.

 

here’s a confidence boost for you. Merck has 980 clinical trials with pembro listed on clinical trials.gov

Combos with other classes of drugs and most every malignancy known.